Yso 2
Alternative Names: Yso-2Latest Information Update: 09 Jul 2021
Price :
$50 *
At a glance
- Originator YSOPIA Bioscience
- Developer National Institute for Agricultural Research; YSOPIA Bioscience
- Class Anti-inflammatories; Bacteria
- Mechanism of Action Bacteria replacements; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Crohn's disease
Most Recent Events
- 01 Jul 2021 Preclinical trials in Crohn’s diseasein France (PO) (YSOPIA Bioscience pipeline, July 2021)
- 27 Jan 2021 Early research in Crohn’s disease in France (PO) (YSOPIA bioscience pipeline, January 2021)
- 27 Jan 2021 YSOPIA bioscience announces intention to file IND for Inflammatory bowel diseases by the end of 2021 (YSOPIA bioscience pipeline, January 2021)